108 related articles for article (PubMed ID: 25788388)
21. A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma.
Sanz-Altamira PM; Ferrante K; Jenkins RL; Lewis WD; Huberman MS; Stuart KE
Cancer; 1998 Jun; 82(12):2321-5. PubMed ID: 9635523
[TBL] [Abstract][Full Text] [Related]
22. Clinical presentation and outcomes of patients with biliary malignancies: the Aga Khan University experience.
Kumar S; Masood N; Shaikh AJ; Valimuhammad AT; Haider G; Lal A; Niamatullah N
Asian Pac J Cancer Prev; 2009; 10(3):463-6. PubMed ID: 19640192
[TBL] [Abstract][Full Text] [Related]
23. Hepatic intra-arterial interferon alpha 2b-based immunotherapy combined with 5-fluorouracil (5-FU)-based systemic chemotherapy for patients with hepatocellular carcinoma (HCC) not responsive and/or not eligible for conventional treatments: a pilot study.
Vitale FV; Romeo P; Vasta F; Panebianco V; Calì S; Rotondo S; Ferraù F; La Greca M
Anticancer Res; 2007; 27(6B):4077-81. PubMed ID: 18225574
[TBL] [Abstract][Full Text] [Related]
24. Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial.
Whittington R; Neuberg D; Tester WJ; Benson AB; Haller DG
J Clin Oncol; 1995 Jan; 13(1):227-32. PubMed ID: 7799024
[TBL] [Abstract][Full Text] [Related]
25. A phase II study of LFP therapy (5-FU (5-fluorourasil) continuous infusion (CVI) and Low-dose consecutive (Cisplatin) CDDP) in advanced biliary tract carcinoma.
Kobayashi K; Tsuji A; Morita S; Horimi T; Shirasaka T; Kanematsu T
BMC Cancer; 2006 May; 6():121. PubMed ID: 16677397
[TBL] [Abstract][Full Text] [Related]
26. A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers.
Denlinger CS; Meropol NJ; Li T; Lewis NL; Engstrom PF; Weiner LM; Cheng JD; Alpaugh RK; Cooper H; Wright JJ; Cohen SJ
Clin Colorectal Cancer; 2014 Jun; 13(2):81-6. PubMed ID: 24512954
[TBL] [Abstract][Full Text] [Related]
27. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of gemcitabine combined with 5-fluorouracil and cisplatin (GFP) in patients for unresectable biliary carcinoma.
Morine Y; Shimada M; Ikegami T; Imura S; Kanemura H; Arakawa Y; Hanaoka J; Kanamoto M; Nii A
Hepatogastroenterology; 2009; 56(90):307-12. PubMed ID: 19579588
[TBL] [Abstract][Full Text] [Related]
29. Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion.
Obi S; Yoshida H; Toune R; Unuma T; Kanda M; Sato S; Tateishi R; Teratani T; Shiina S; Omata M
Cancer; 2006 May; 106(9):1990-7. PubMed ID: 16565970
[TBL] [Abstract][Full Text] [Related]
30. BINGO: targeted therapy for advanced biliary-tract cancer.
Valle JW
Lancet Oncol; 2014 Jul; 15(8):778-80. PubMed ID: 24852117
[No Abstract] [Full Text] [Related]
31. Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer.
Patt YZ; Hassan MM; Lozano RD; Waugh KA; Hoque AM; Frome AI; Lahoti S; Ellis L; Vauthey JN; Curley SA; Schnirer II; Raijman I
Clin Cancer Res; 2001 Nov; 7(11):3375-80. PubMed ID: 11705850
[TBL] [Abstract][Full Text] [Related]
32. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.
Takada T; Amano H; Yasuda H; Nimura Y; Matsushiro T; Kato H; Nagakawa T; Nakayama T;
Cancer; 2002 Oct; 95(8):1685-95. PubMed ID: 12365016
[TBL] [Abstract][Full Text] [Related]
33. A Phase II study of intravenous exatecan administered daily for 5 days, every 3 weeks to patients with biliary tract cancers.
Abou-Alfa GK; Rowinsky EK; Patt YZ; Schwartz GK; Kelsen DP; Sharma S; Siegel E; Becerra CR; Eckhardt SG; Feit K; De Jager R; O'Reilly EM
Am J Clin Oncol; 2005 Aug; 28(4):334-9. PubMed ID: 16062073
[TBL] [Abstract][Full Text] [Related]
34. Hepatic arterial infusion of 5-fluorouracil in combination with subcutaneous interferon-alpha for advanced hepatocellular carcinoma.
Kuroda M; Kobayashi Y; Urawa N; Yamamoto M; Mifuji R; Araki J; Tanaka H; Horiike S; Itani T; Furjita N; Konishi M; Iwasa M; Kaito M; Adachi Y
Hepatogastroenterology; 2007 Mar; 54(74):518-21. PubMed ID: 17523311
[TBL] [Abstract][Full Text] [Related]
35. Radiotherapy combined with transarterial infusion chemotherapy and concurrent infusion of a vasoconstrictor agent for nonresectable advanced hepatic hilar duct carcinoma.
Matsumoto S; Kiyosue H; Komatsu E; Wakisaka M; Tomonari K; Hori Y; Matsumoto A; Mori H
Cancer; 2004 Jun; 100(11):2422-9. PubMed ID: 15160347
[TBL] [Abstract][Full Text] [Related]
36. Precision hepatic arterial irinotecan therapy in the treatment of unresectable intrahepatic cholangiocellular carcinoma: optimal tolerance and prolonged overall survival.
Schiffman SC; Metzger T; Dubel G; Andrasina T; Kralj I; Tatum C; McMasters KM; Scoggins CR; Martin RC
Ann Surg Oncol; 2011 Feb; 18(2):431-8. PubMed ID: 20862554
[TBL] [Abstract][Full Text] [Related]
37. Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma.
Patt YZ; Hassan MM; Aguayo A; Nooka AK; Lozano RD; Curley SA; Vauthey JN; Ellis LM; Schnirer II; Wolff RA; Charnsangavej C; Brown TD
Cancer; 2004 Aug; 101(3):578-86. PubMed ID: 15274071
[TBL] [Abstract][Full Text] [Related]
38. [A case report: successful resection of advanced intrahepatic cholangiocarcinoma responding to preoperative hepatic artery infusion of 5-FU].
Hasuike Y; Motoori M; Hattori T; Fujita J; Mishima H; Sawamura T; Nishishou I; Kikkawa N; Sai H; Hosoki T; Mitomo M
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1909-12. PubMed ID: 10560423
[TBL] [Abstract][Full Text] [Related]
39. Mass reduction by radiofrequency ablation before hepatic arterial infusion chemotherapy improved prognosis for patients with huge hepatocellular carcinoma and portal vein thrombus.
Hirooka M; Koizumi Y; Kisaka Y; Abe M; Murakami H; Matsuura B; Hiasa Y; Onji M
AJR Am J Roentgenol; 2010 Feb; 194(2):W221-6. PubMed ID: 20093578
[TBL] [Abstract][Full Text] [Related]
40. Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab.
Cercek A; D'Angelica M; Power D; Capanu M; Gewirtz A; Patel D; Allen P; Fong Y; DeMatteo RP; Jarnagin WR; Kemeny NE
Ann Surg Oncol; 2014 Feb; 21(2):479-86. PubMed ID: 24154839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
